EXANTE has pushed ahead with its plans to broaden its cryptocurrency offering, today rolling out trading support for Ravencoin’s RVN, the native token of a P2P blockchain built around the open-source project of the same name.
Launched in January 2018, Ravencoin revolves around enabling easier creation and distribution of crypto assets and tokens from one holder to another in its ecosystem. It has established itself as a peer-to-peer platform focused on instant payments and token issuance.
RVN token is already available on major crypto exchanges including Bittrex, Binance, Upbit, and Bitrue.
The coin has scaled up by over 50 percent since its inception and has recently entered the list of top 50 cryptocurrencies by market capitalization. RVN market cap rose from $40 billion in February to over $270 in June but currently stands at nearly $150 million.
Royal C Bank on Why Crypto is Still the Name of the GameGo to article >>
A crypto offering from the very beginning
In addition to RVN, EXANTE customers can already trade over 20 funds pegged to crypto assets. The Malta-based broker debuted its Bitcoin-only hedge fund back in 2013. At the time, cryptocurrency trading was carried out through EXANTE crypto funds, which allow buying bitcoin and 15 popular altcoins.
Also in 2017, Exante launched a dedicated altcoin index, XAI, which allows clients to speculate on prices of popular alternative cryptocurrencies. XAI Fund is secured by the real cryptocurrencies included in the index, and it did not include Bitcoin into the list to make the offering more diversified.
EXANTE has been one of the few brokers that jumped on the cryptocurrency bandwagon from the very beginning. The company started the Bitcoin fund six years ago, which allowed trading that specific cryptocurrency, then added more popular altcoins such as Litecoin, Ethereum, Monero, Zcash, and Ripple.
Finance Magnates also reported on Exante last year when its new venture capital fund ‘Exantech’ announced its first investment – $10 million in cryptocurrency miner Comino.